Considering genomic disruption levels of disease-free CTCs and relapsed patients CTCs, we observed a highly significant difference between the two groups.
← all excerpts
CNA Profiling of Single CTCs in Locally Advanced Esophageal Cancer Patients during Therapy Highlights Unexplored Molecular Pathways.
1
—
—